< Back to Press Releases

Monthly Archives: September 2013

Diabetes increases the risk of developing and dying from breast and colon cancer

Amsterdam, The Netherlands: Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of … Continue reading

Published Sunday, September 29th, 2013 at 12:01 am
Posted in Cancer

Everolimus slows disease progression in advanced papillary kidney cancer patients

Amsterdam, The Netherlands: The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the … Continue reading

Published Sunday, September 29th, 2013 at 12:01 am
Posted in Cancer

Young patients with metastatic colorectal cancer are at high risk of disease progression and death

Amsterdam, The Netherlands: Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they … Continue reading

Published Sunday, September 29th, 2013 at 12:01 am
Posted in Cancer

Treating chest lymph nodes in patients with early breast cancer improves survival without increasing side effects

Amsterdam, The Netherlands: Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects. This new finding ends the uncertainty about … Continue reading

Published Saturday, September 28th, 2013 at 2:00 pm
Posted in Cancer

Hyperfractionated radiotherapy improves survival in head and neck cancer patients

Amsterdam, The Netherlands: The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study presented on Saturday … Continue reading

Published Saturday, September 28th, 2013 at 2:00 pm
Posted in Cancer

Longest follow-up of largest number of melanoma patients treated with ipilimumab shows some survive up to ten years

Amsterdam, The Netherlands: Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients, presented at the 2013 European Cancer … Continue reading

Published Saturday, September 28th, 2013 at 11:15 am
Posted in Cancer

Anti-cancer drug T-DM1 benefits women with advanced breast cancer who have failed several previous treatments: results from TH3RESA trial

Amsterdam, The Netherlands: First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive breast cancer whose cancer has … Continue reading

Published Saturday, September 28th, 2013 at 12:01 am
Posted in Cancer, Genetics

First randomised trial of targeted cancer medicine in all tumour types to be presented at ECC2013; results will pave the way for personalised treatment

A further step along the road to the personalisation of cancer medicine, where treatment is based on the individual molecular characteristics of tumours rather than their primary site, will be presented at the 2013 European Cancer Congress (ECC2013), which starts … Continue reading

Published Thursday, September 12th, 2013 at 12:01 am
Posted in Cancer, Genetics
.